Related Experiment Video
Updated: Feb 6, 2026

Porcine As a Training Module for Head and Neck Microvascular Reconstruction
Published on: September 29, 2018
Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer
Phuong Thao Nguyen1,2,3, Dung Nguyen1, Chanbora Chea1
1Department of Oral and Maxillofacial Pathobiology, Basic Life Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Abstract:
N-cadherin is a neural cell adhesion molecule that aberrantly occurs in head and neck cancers to promote cancer cell growth. However, the underlying mechanisms remain unclear. Here we report that N-cadherin increases cancer cell growth by inhibiting apoptosis. Apoptosis eliminates old, unnecessary, and unhealthy cells. However, tumor cells have the ability of avoiding apoptosis that increases cancer cell growth. Recent studies have found that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cells by reacting with four distinct cell surface receptors: TRAIL-R1 (DR-4), TRAIL-R2 (DR-5), TRAIL-R3 (DcR-1), and TRAIL-R4 (DcR-2). Among these TRAIL receptors, the death receptors DR-4 and DR-5 transmit apoptotic signals owing to the death domain in the intracellular portion. Conversely, the decoy receptors DcR-1 and DcR-2 lack a complete intracellular portion, so neither can transmit apoptotic signals. DcR-1 or DcR-2 overexpression suppresses TRAIL-induced apoptosis. In this study, N-cadherin overexpression increased DcR-2 expression and decreased DR-5 expression. In contrast, knockdown of N-cadherin expression upregulated DR-5 expression and downregulated DcR-2 expression. A significantly positive relationship between N-cadherin and DcR-2 expression was also found in HNSCC specimens. Those specimens with a lower apoptotic index showed a higher expression of N-cadherin and/or DcR-2. In addition, we demonstrated that N-cadherin interacts directly with DcR-2. Notably, DcR-2 induces cancer cell survival through the cleavage of caspases and PARP by activating MAPK/ERK pathway and suppressing NF-kB/ p65 phosphorylation, which has a very important role in resistance to chemotherapy.
Insights
N-cadherin promotes head and neck cancer growth by blocking apoptosis. It increases decoy receptor DcR-2 and decreases death receptor DR-5, aiding tumor cell survival and chemotherapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- N-cadherin, a neural cell adhesion molecule, is implicated in head and neck squamous cell carcinoma (HNSCC) progression.
- Tumor cells evade apoptosis, a key mechanism for cancer cell survival and growth.
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors, including death receptors (DR-4, DR-5) and decoy receptors (DcR-1, DcR-2), regulate apoptosis.
Purpose of the Study:
- To elucidate the mechanism by which N-cadherin promotes cancer cell growth in HNSCC.
- To investigate the role of N-cadherin in regulating TRAIL receptor expression and apoptosis.
- To determine the functional interaction between N-cadherin and TRAIL receptors in HNSCC survival.
Main Methods:
- Analysis of N-cadherin, DR-5, and DcR-2 expression in HNSCC cells and patient specimens.
- N-cadherin knockdown and overexpression experiments.
- Assessment of apoptotic index and cell signaling pathways (MAPK/ERK, NF-kB).
- Co-immunoprecipitation to confirm N-cadherin and DcR-2 interaction.
Main Results:
- N-cadherin overexpression upregulated DcR-2 and downregulated DR-5, while N-cadherin knockdown had the opposite effect.
- A positive correlation was observed between N-cadherin and DcR-2 expression in HNSCC specimens with low apoptotic indices.
- N-cadherin directly interacts with DcR-2, leading to suppressed apoptosis via MAPK/ERK activation and inhibited NF-kB signaling.
- This interaction contributes to chemotherapy resistance by protecting cancer cells from apoptosis.
Conclusions:
- N-cadherin enhances HNSCC growth by inhibiting apoptosis through modulation of TRAIL receptor expression.
- The interaction between N-cadherin and DcR-2 plays a critical role in promoting cancer cell survival and chemoresistance.
- Targeting N-cadherin or its interaction with DcR-2 may represent a therapeutic strategy for HNSCC.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
09:16The Chick Chorioallantoic Membrane In Vivo Model to Assess Perineural Invasion in Head and Neck Cancer
Published on: June 21, 2019
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Structure of Cadherins
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Apoptosis